Edition:
United Kingdom

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

9.01USD
19 Apr 2018
Change (% chg)

$-0.33 (-3.53%)
Prev Close
$9.34
Open
$9.31
Day's High
$9.41
Day's Low
$8.97
Volume
115,978
Avg. Vol
--
52-wk High
$38.68
52-wk Low
$7.94

Chart for

About

Menlo Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions, such as atopic dermatitis, psoriasis and prurigo nodularis. It is also evaluating the use of serlopitant for the... (more)

Overall

No Ratios Available.

Financials

  MNLO.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -- -- --
ROI: -- 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Menlo Therapeutics Reports Q4 Loss Of $1.80 Per Share

* MENLO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

28 Mar 2018

BRIEF-Novo Holdings Reports 5.05 Pct Passive Stake In Menlo Therapeutics

* NOVO HOLDINGS A/S REPORTS 5.05 PERCENT PASSIVE STAKE IN MENLO THERAPEUTICS INC, AS OF JANUARY 29, 2018 - SEC FILING‍​ Source text: (http://bit.ly/2nSBUJu) Further company coverage:

08 Feb 2018

BRIEF-Menlo Therapeutics Now Sees IPO Of 6.5 Mln Shares Of Common Stock Priced Between $16 And $17 Per Share

* MENLO THERAPEUTICS INC NOW SEES IPO OF 6.5 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $16.00 AND $17.00 PER SHARE - SEC FILING

23 Jan 2018

Earnings vs. Estimates